fbpx

Dr. Luis Manzano

Head of Internal Medicine

Director, Heart Failure & Vascular Risk Unit, Ramón y Cajal University Hospital Madrid, Spain Professor of Medicine, Department of Medicine

Director, Centro de Apoyo a la Docencia, University of Alcalá, Alcalá de Henares, Spain

EDUCATION

  1. MD     University of Granada, Spain

1991     PhD     University Autónoma of Madrid, Spain

TRAINING

  1. Internal Medicine Residency, Puerta de Hierro Hospital, Madrid, Spain, Number 4 in the 1983 national MIR exam.

2014               Fellow of ESC

PROFESSIONAL EXPERIENCE

1989-1990      Staff Physician, Department of Internal Medicine, Puerta de Hierro Hospital, Madrid, Spain

1989-1990      Research Coordinator, Laboratory of Investigation, Department of Internal Medicine, Puerta de Hierro Hospital, Madrid, Spain

1990-1996      Staff Physician, Department of Internal Medicine, Príncipe de Asturias Hospital, Alcalá de Henares, Spain

1990-1996      Assistant Professor of Medicine, Department of Medicine, Alcalá University, Alcalá de Henares, Spain

1990-present   Senior Research Member, Research Laboratory of the Department Medicine, Alcalá University, Alcalá de Henares, Spain

1996-present   Professor of Medicine, Department of Medicine, University of Alcalá, Alcalá de Henares, Spain

1996-2004      Staff Physician, Department of Internal Medicine, Ramón y Cajal Hospital, Madrid, Spain

2004-present   Director, Heart Failure & Vascular Risk Unit, Department of Internal Medicine, Ramón y Cajal University Hospital, Madrid, Spain.

2007-2008      Honorary Consultant and Visiting Professor. Royal Brompton Hospital. Imperial College. London

2011-present   Director, Centro de Apoyo a la Docencia en Ciencias de la Salud. University of Alcalá, Alcalá de Henares, Spain

RESEARCH HIGHLIGHTS

Since 2004, as director of the Heart Failure & Vascular Risk, the principal area of interest and expertise are cardiovascular diseases in the elderly, particularly heart failure and peripheral arterial disease. We are also very interested in models of heart failure program management based on a permanent and integral follow up.

The research in the Laboratory of the Department of Medicine involves the pathophysiological role of the immune-inflammatory response in several clinical models. At this time we are focused about biological mechanisms implicated in atherosclerosis and heart failure

PUBLICATIONS

The clinical and experimental research has been published in more than 140 peer-reviewed journals, including Lancet, European Heart Journal, Journal of American College of Cardiology, BMJ, New England Journal of Medicine, European Journal of Heart Failure, International Journal of Cardiology, European Journal of Internal Medicine, American Heart Journal, Journal of Thrombosis and Haemostasis, Atherosclerosis, Stroke, Hypertension, Cochrane Database of Systematic Reviews, Journal of the American Society of Nephrology, Blood, Gastroenterology, Journal of Clinical Immunology, Hepatology, Gut, Journal of Hepatology, Cancer, British Journal of Cancer, Medicina Clínica, Revista Española de Cardiología, or Revista Clínica Española.



Ponente en los siguientes cursos: